Skip to main content

Table 5 UK patients with acquired angioedema

From: Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom

Patient no.

Gender

Age at IOS enrolment, years

Icatibant-treated angioedema attacksa, n

HCP-administered icatibant injections, n

Self-administered icatibant injections, n

1

Male

50.5

53

3

51

2

Male

63.1

27

6

22

3

Female

49.7

2

1

1

4

Male

70.9

1

–

1

5

Female

28.6

0

–

–

6

Female

59.8

0

–

–

7

Female

38.4

0

–

–

  1. HCP healthcare professional, IOS Icatibant Outcome Survey
  2. aJuly 2009 to July 2016